Active	Status	Sponsor type	Region	Phase	Filter
8 Active 4 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Smith, Douglas
NCT03758131: Peer MI in FQHCs for Substance-using Emerging Adults	Not yet recruiting	2	150	US	Peer-enhanced Motivational Interviewing, PMI, Motivational Interviewing, MI, Waitlist Control, WC	University of Illinois at Urbana-Champaign, University of Washington	Substance Use Disorders	02/24	02/24
NCT05676099: TSC Biosample Repository and Natural History Database	Recruiting	N/A	5000	Canada, US	Phlebotomy, Buccal (cheek) swab, Genetic Testing, Tissue donation after routine clinical procedure	National Tuberous Sclerosis Association	Tuberous Sclerosis, Lymphangioleiomyomatosis	12/50	12/50
Weiner, Howard
MANIFEST-2, NCT04603495 / 2020-001989-10: Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) Jan 2024 - Dec 2024: Approval for myelofibrosis Jul 2024 - Dec 2024 : Regulatory submission in EU for 1L myelofibrosis Jan 2024 - Mar 2024: From MANIFEST-2 trial in combination with ruxolitinib as a first-line treatment for patients with myelofibrosis Feb 2024 - Feb 2024: Completion of P2b trial for JIA Feb 2024 - Feb 2024: Exclusivity expiry in US	Active, not recruiting	3	430	Europe, Canada, US, RoW	Pelabresib, Ruxolitinib, Placebo	Constellation Pharmaceuticals	Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis	08/23	12/27
SL03-OHD-104, NCT05275439: Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects with MDS or AML	Active, not recruiting	1	160	Europe, Canada, US	SL-172154, Azacitidine, Venetoclax	Shattuck Labs, Inc.	Acute Myeloid Leukemia, Myelodysplastic Syndromes	11/24	11/24
NCT05676099: TSC Biosample Repository and Natural History Database	Recruiting	N/A	5000	Canada, US	Phlebotomy, Buccal (cheek) swab, Genetic Testing, Tissue donation after routine clinical procedure	National Tuberous Sclerosis Association	Tuberous Sclerosis, Lymphangioleiomyomatosis	12/50	12/50
Belen, Emanuel
NCT05676099: TSC Biosample Repository and Natural History Database	Recruiting	N/A	5000	Canada, US	Phlebotomy, Buccal (cheek) swab, Genetic Testing, Tissue donation after routine clinical procedure	National Tuberous Sclerosis Association	Tuberous Sclerosis, Lymphangioleiomyomatosis	12/50	12/50
Wisor-Martinez, Sarah
NCT05676099: TSC Biosample Repository and Natural History Database	Recruiting	N/A	5000	Canada, US	Phlebotomy, Buccal (cheek) swab, Genetic Testing, Tissue donation after routine clinical procedure	National Tuberous Sclerosis Association	Tuberous Sclerosis, Lymphangioleiomyomatosis	12/50	12/50
Fletcher, RC
NCT05676099: TSC Biosample Repository and Natural History Database	Recruiting	N/A	5000	Canada, US	Phlebotomy, Buccal (cheek) swab, Genetic Testing, Tissue donation after routine clinical procedure	National Tuberous Sclerosis Association	Tuberous Sclerosis, Lymphangioleiomyomatosis	12/50	12/50